Skip to content

All recalls FDA

FDADrugsRecalled Status: Closed by the agency

Teva Pharmaceuticals USA, Inc recalls Tri-Lo-Sprintec (norgestimate and ethinyl estradiol) tablets USP - triphasic regimen

Class IIofficial

FDA Class II

FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.

Hazard
Failed Dissolution Specifications
Products
  • Tri-Lo-Sprintec (norgestimate and ethinyl estradiol) tablets USP - triphasic regimen
Where it was sold

USA nationwide.

Nationwide

Units affected
92,676 cartons
About this recall
Tri-Lo-Sprintec (norgestimate and ethinyl estradiol) tablets USP - triphasic regimen, packaged in carton containing 3 Blister Cards, 28 Tablets Each, Rx only, Teva Pharmaceuticals USA, INC, North Wales, PA 19454, NDC 0093-2140-62